Related Experiment Videos
Plasma GABA in affective illness. A preliminary investigation
Journal of Affective Disorders
|December 1, 1981
Summary
This study found that plasma gamma-aminobutyric acid (GABA) levels differ across affective disorders. Lowest GABA levels were observed in familial pure depressive and depression spectrum diseases, while bipolar mania showed elevated GABA.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system.
- Dysregulation of GABAergic systems has been implicated in various psychiatric disorders, including depression and bipolar disorder.
Purpose of the Study:
- To investigate plasma GABA levels in patients diagnosed with different subtypes of affective disorders.
- To compare GABA levels between patient groups and healthy controls.
Main Methods:
- Plasma samples were collected from 34 patients with affective disorders and 20 healthy controls.
- Plasma GABA concentrations were measured using a specified analytical method (details not provided in abstract).
Main Results:
- Patients with familial pure depressive disease and depression spectrum disease exhibited the lowest plasma GABA levels.
- Sporadic depressive disease patients showed significantly lower GABA levels than controls, but higher than the other depressive subtypes.
- Plasma GABA levels in secondary depression and bipolar depression were comparable to controls.
- Bipolar manic patients displayed significantly higher plasma GABA levels compared to controls.
Conclusions:
- Plasma GABA levels may serve as a potential biomarker for differentiating subtypes of affective disorders.
- Specific depressive subtypes are associated with reduced GABAergic activity, while mania may involve GABAergic hyperactivity.